Hidenori Ojima

6PUBLICATIONS
24CO-AUTHORS
Predictive and prognostic markersCancer diagnosisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 04, 2026
VEGF-Positive Mass-Forming Intrahepatic Cholangiocarcinoma: New Subtype Based on Radiological and Molecular Pathological Analysis.

Junya Tsuzaki, Naoto Kubota, Shigeyoshi Soga

|Feb 01, 2026
Gross Intrahepatic Mass Formation Predicts the Primary Site of Perihilar Cholangiocarcinoma Based on Molecular Pathologic Studies.

Yuki Masuda, Naoto Kubota, Ryo Takemura

|Dec 30, 2025
High Immunohistochemical Expression of SETD5 as a Candidate Pathological Factor for Dedifferentiation and Prognosis in Liposarcoma.

Makoto Abe, Naoto Kubota, Ken Yamazaki

|Oct 17, 2024
Spatial Dynamics of T- and B-Cell Responses Predicts Clinical Outcome of Resectable and Unresectable Hepatocellular Carcinoma.

Yutaka Kurebayashi, Katsutoshi Sugimoto, Hanako Tsujikawa

|May 16, 2023
Surgical and Oncological Outcomes of Salvage Hepatectomy for Locally Recurrent Hepatocellular Carcinoma after Locoregional Therapy: A Single-Institution Experience.

Takuya Minagawa, Osamu Itano, Minoru Kitago

|Sep 06, 2019
Synergistic and Pharmacotherapeutic Effects of Gemcitabine and Cisplatin Combined Administration on Biliary Tract Cancer Cell Lines.

Yasunari Sakamoto, Seri Yamagishi, Takuji Okusaka

Pageof 1

Frequent Collaborators

3 joint publications

Naoto Kubota

2 joint publications

Osamu Itano

1 joint publications

Yasunari Sakamoto

1 joint publications

Seri Yamagishi